Clinical trial
Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in…
NCT00383695 · Royal Marsden NHS Foundation Trust, Other · Unknown status
Key facts
| NCT number | NCT00383695 |
|---|---|
| Title | Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer |
| Official title | A Multicentre Randomised Phase II Clinical Trial Comparing Oxaliplatin (Eloxatin), Capecitabine (Xeloda) and Pre-Operative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision for the Treatment of Patients With Magnetic Resonance Imaging (MRI) Defined High Risk Rectal Cancer |
| Acronym | EXPERT-C |
| Lead sponsor | Royal Marsden NHS Foundation Trust, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | cetuximab, capecitabine, oxaliplatin, adjuvant therapy, conventional surgery, neoadjuvant therapy, radiation therapy |
| Enrollment | 164 |
| Start date | Sep 1, 2005 |
| First posted | Oct 3, 2006 |
| Last update posted | Jan 13, 2010 |
| Countries | Spain, Sweden, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: